[REVISION HISTORY]

Pharmaceutical pricing trends in Serbia

1 recorded revision of this situation.

What changed

2026-10-14 12:09 UTC → 2026-10-18 22:49 UTC · added ~~removed~~

In Serbia, pharmaceutical prices increased by 7.8 percent in September compared to the previous year, despite government efforts to mitigate costs. Former President Aleksandar Vučić had previously announced a relief package of approximately 104.8 million euros (12.3 billion dinars) intended to expand the list of state-subsidized prescription drugs and lower patient co-payments. ~~Economists have noted~~ Prime Minister Đuro Macut announced that 18 new prescription drugs, including oral anticoagulants, would be covered by the state starting in mid-August. However, economists suggest that pharmaceutical companies may be increasing prices on non-subsidized products to offset lost profits. ~~While some critics have described~~ The rising costs are placing significant financial strain on vulnerable populations. In 2025, the ~~government's price reduction measures as “primarily political maneuvers,” experts suggest that patients can manage~~ poverty risk for those aged 65 and older was 25.8 percent, while the poverty risk among pensioners stood at 23.4 percent. For many elderly citizens, managing fixed incomes against the rising costs ~~by requesting generic alternatives to brand-name medications.~~ of food, utilities, and essential healthcare remains a critical challenge.

Versions

Select a version to see what changed compared to the one before it.